217 related articles for article (PubMed ID: 16858363)
21. Variability in platelet response to the antiplatelet agents aspirin and clopidogrel: mechanisms, measurement, and clinical relevance.
Jennings LK
Crit Pathw Cardiol; 2009 Mar; 8(1):20-8. PubMed ID: 19258834
[TBL] [Abstract][Full Text] [Related]
22. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
23. Clopidogrel as an antiplatelet agent in transplant heart coronary stenting.
Mahadevan VS; Khan MM; Adgey JA
J Interv Cardiol; 2002 Jun; 15(3):197-9. PubMed ID: 12141144
[TBL] [Abstract][Full Text] [Related]
24. Successful Prasugrel Therapy for Recurrent Left Main Stent Thrombosis in a Clopidogrel Hyporesponder.
Kim YS; Lee SR
Tex Heart Inst J; 2015 Oct; 42(5):483-6. PubMed ID: 26504448
[TBL] [Abstract][Full Text] [Related]
25. Identifying clopidogrel resistance during chronic therapy: the case for a biochemical approach.
Horowitz JD; Chirkov YY
Thromb Haemost; 2008 Oct; 100(4):519-20. PubMed ID: 18841269
[No Abstract] [Full Text] [Related]
26. [New antiplatelet agents (platelet receptor blockers): has aspirin come out of place?].
Tsakiris DA
Praxis (Bern 1994); 2004 Jun; 93(23):1003-5. PubMed ID: 15233569
[No Abstract] [Full Text] [Related]
27. [Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction].
Kremneva LV; Shalaev SV
Ter Arkh; 2008; 80(12):89-95. PubMed ID: 19227916
[No Abstract] [Full Text] [Related]
28. Studies published on clopidogrel-aspirin for coronary stent placement.
Miller JL
Am J Health Syst Pharm; 2000 Jan; 57(2):101-2. PubMed ID: 10688234
[No Abstract] [Full Text] [Related]
29. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
[TBL] [Abstract][Full Text] [Related]
30. An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events.
Terpening C
J Am Board Fam Med; 2009; 22(1):51-6. PubMed ID: 19124633
[TBL] [Abstract][Full Text] [Related]
31. [Antiplatelet drugs in prevention of complications of arteriosclerotic diseases: it is necessary to move beyond aspirin].
Shalaev SV
Kardiologiia; 2003; 43(6):84-7. PubMed ID: 13677328
[No Abstract] [Full Text] [Related]
32. Clopidogrel in coronary artery disease: update 2012.
Huber K
Adv Cardiol; 2012; 47():31-8. PubMed ID: 22906901
[TBL] [Abstract][Full Text] [Related]
33. [Clopidogrel resistance].
Güray Y; Güray U; Korkmaz S
Anadolu Kardiyol Derg; 2009 Jun; 9(3):231-7. PubMed ID: 19520658
[TBL] [Abstract][Full Text] [Related]
34. Stroke and the statistics of the aspirin/clopidogrel secondary prevention trials.
Howard G; McClure LA; Krakauer JW; Coffey CS
Curr Opin Neurol; 2007 Feb; 20(1):71-7. PubMed ID: 17215692
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox".
Motovska Z; Widimsky P; Petr R; Bilkova D; Marinov I; Simek S; Kala P;
J Cardiovasc Pharmacol; 2009 May; 53(5):368-72. PubMed ID: 19247187
[TBL] [Abstract][Full Text] [Related]
36. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
[TBL] [Abstract][Full Text] [Related]
37. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
Valgimigli M; Campo G; de Cesare N; Meliga E; Vranckx P; Furgieri A; Angiolillo DJ; Sabatè M; Hamon M; Repetto A; Colangelo S; Brugaletta S; Parrinello G; Percoco G; Ferrari R;
Circulation; 2009 Jun; 119(25):3215-22. PubMed ID: 19528337
[TBL] [Abstract][Full Text] [Related]
38. Antiplatelet therapy in percutaneous coronary intervention: is variability of response clinically relevant?
Curzen N; Sambu N
Heart; 2011 Sep; 97(17):1433-40. PubMed ID: 21821634
[No Abstract] [Full Text] [Related]
39. Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial).
Dasgupta A; Steinhubl SR; Bhatt DL; Berger PB; Shao M; Mak KH; Fox KA; Montalescot G; Weber MA; Haffner SM; Dimas AP; Steg PG; Topol EJ;
Am J Cardiol; 2009 May; 103(10):1359-63. PubMed ID: 19427428
[TBL] [Abstract][Full Text] [Related]
40. Benefit of aspirin not surpassed by combining clopidogrel with aspirin in dual anti-platelet prevention of atherothrombotic events in high-risk patients : drug trends in cardiology.
Cardiovasc J S Afr; 2006; 17(2):96, 98; discussion 98. PubMed ID: 16733607
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
